Revvity outlines 3%-4% 2026 organic growth and $5.20-$5.30 EPS while planning China immunodiagnostics divestiture
Revvity, Inc. · LABORATORY ANALYTICAL INSTRUMENTS · Now $100.52
+9.4% in 3d after detection
Post-detection moves
1h
—
1d
+7.4%
3d
+9.4%
7d
+4.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS